Urotronic Announces Presentation of Data from Two Clinical Trials Evaluating Optilume® BPH System’s Effectiveness and Durability

Dr. Steven A. Kaplan presented positive 4-year and 12-month clinical outcomes during the American Urological Association’s Annual Meeting MINNEAPOLIS, May 1, 2023 /PRNewswire/ — Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated…